BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 18665847)

  • 1. The effect of Staphylococcus aureus carriage in late pregnancy on antibody levels to staphylococcal toxins in cord blood and breast milk.
    Harrison LM; Morris JA; Lauder RM; Telford DR
    FEMS Immunol Med Microbiol; 2008 Oct; 54(1):137-43. PubMed ID: 18665847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of specific antibodies in cord blood, infant and maternal saliva and breast milk to staphylococcal toxins implicated in sudden infant death syndrome (SIDS).
    Harrison LM; Morris JA; Bishop LA; Lauder RM; Taylor CA; Telford DR
    FEMS Immunol Med Microbiol; 2004 Sep; 42(1):94-104. PubMed ID: 15325402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against superantigenic exotoxins produced by Staphylococcus aureus in sera from mothers and their infants' cord blood.
    Takahashi N; Hattori M; Miwa K; Nishida H
    Am J Perinatol; 2006 Oct; 23(7):413-9. PubMed ID: 17004199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new exanthematous disease in newborn infants caused by exotoxins producing Staphylococcus aureus; exotoxins production of the isolates and serum levels of antitoxin antibody in the patients and umbilical cord blood].
    Okada T; Furukawa S; Miwa K; Sakai R; Sugiyama J
    Kansenshogaku Zasshi; 1999 Sep; 73(9):893-900. PubMed ID: 10535264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcal pyrogenic toxins in infant urine samples: a possible marker of transient bacteraemia.
    Harrison LM; Morris JA; Lauder RM; Telford DR
    J Clin Pathol; 2009 Aug; 62(8):735-8. PubMed ID: 19465408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus.
    Verkaik NJ; de Vogel CP; Boelens HA; Grumann D; Hoogenboezem T; Vink C; Hooijkaas H; Foster TJ; Verbrugh HA; van Belkum A; van Wamel WJ
    J Infect Dis; 2009 Mar; 199(5):625-32. PubMed ID: 19199541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic shock syndrome toxin-1 (TSST-1) antibody levels in Japanese children.
    Quan L; Morita R; Kawakami S
    Burns; 2010 Aug; 36(5):716-21. PubMed ID: 20036064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective effect of breast feeding in relation to sudden infant death syndrome (SIDS): III. Detection of IgA antibodies in human milk that bind to bacterial toxins implicated in SIDS.
    Gordon AE; Saadi AT; MacKenzie DA; Molony N; James VS; Weir DM; Busuttil A; Blackwell CC
    FEMS Immunol Med Microbiol; 1999 Aug; 25(1-2):175-82. PubMed ID: 10443506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of toxic shock syndrome toxin-1 producing Staphylococcus aureus and the anti TSST-1 serostatus of hospital personnel in Nigeria.
    Olusanya O; Naidu AS
    East Afr Med J; 1991 Jul; 68(7):507-14. PubMed ID: 1756702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of toxins during Staphylococcus aureus infection.
    Verkaik NJ; Dauwalder O; Antri K; Boubekri I; de Vogel CP; Badiou C; Bes M; Vandenesch F; Tazir M; Hooijkaas H; Verbrugh HA; van Belkum A; Etienne J; Lina G; Ramdani-Bouguessa N; van Wamel WJ
    Clin Infect Dis; 2010 Jan; 50(1):61-8. PubMed ID: 19947854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women.
    Parsonnet J; Hansmann MA; Seymour JL; Delaney ML; Dubois AM; Modern PA; Jones MB; Wild JE; Onderdonk AB
    BMC Infect Dis; 2010 Aug; 10():249. PubMed ID: 20731864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia.
    Kanclerski K; Söderquist B; Kjellgren M; Holmberg H; Möllby R
    J Med Microbiol; 1996 Mar; 44(3):171-7. PubMed ID: 8636933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [1st isolation of strains of Staphylococcus aureus producing toxic shock syndrome toxin 1 in food handlers in Argentina].
    Puig de Centorbi ON; López OC; Alcaraz LE; Abdón de Cuadrado AM
    Rev Argent Microbiol; 1990; 22(3):142-5. PubMed ID: 2102013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal immunization of mutant toxic shock syndrome toxin 1 elicits systemic and mucosal immune response against Staphylococcus aureus infection.
    Narita K; Hu DL; Tsuji T; Nakane A
    FEMS Immunol Med Microbiol; 2008 Apr; 52(3):389-96. PubMed ID: 18312579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.
    Parsonnet J; Hansmann MA; Delaney ML; Modern PA; Dubois AM; Wieland-Alter W; Wissemann KW; Wild JE; Jones MB; Seymour JL; Onderdonk AB
    J Clin Microbiol; 2005 Sep; 43(9):4628-34. PubMed ID: 16145118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effect of immunisation against diphtheria, pertussis and tetanus (DPT) in relation to sudden infant death syndrome.
    Essery SD; Raza MW; Zorgani A; MacKenzie DA; James VS; Weir DM; Busuttil A; Hallam N; Blackwell C
    FEMS Immunol Med Microbiol; 1999 Aug; 25(1-2):183-92. PubMed ID: 10443507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis.
    Popa ER; Stegeman CA; Abdulahad WH; van der Meer B; Arends J; Manson WM; Bos NA; Kallenberg CG; Tervaert JW
    Rheumatology (Oxford); 2007 Jun; 46(6):1029-33. PubMed ID: 17409134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcal cell membrane antigen, a possible antigen in post-methicillin resistant Staphylococcus aureus (MRSA) infection nephritis and IgA nephropathy, exhibits high immunogenic activity that is enhanced by superantigen.
    Shimizu Y; Sakurai H; Hirayama K; Seki M; Yoh K; Yamagata K; Koyama A
    J Nephrol; 2005; 18(3):249-56. PubMed ID: 16013011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis.
    Holtfreter S; Roschack K; Eichler P; Eske K; Holtfreter B; Kohler C; Engelmann S; Hecker M; Greinacher A; Broker BM
    J Infect Dis; 2006 May; 193(9):1275-8. PubMed ID: 16586365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.
    Hu DL; Omoe K; Sasaki S; Sashinami H; Sakuraba H; Yokomizo Y; Shinagawa K; Nakane A
    J Infect Dis; 2003 Sep; 188(5):743-52. PubMed ID: 12934191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.